Wednesday, March 22, 2023 | Back issues
Courthouse News Service Courthouse News Service

Federal Circuit

PATENT, EXPERTS - The Federal Circuit partially reversed a $7 million judgment against Abbott Laboratories for infringing on Innogenetics' patented technology for finding and classifying hepatitis C virus genotypes in a biological sample. J. Moore found that expert testimony misunderstood the term "genotyping," but that the failure to use the district court's exact words did not change the substance of the testimony. See ruling.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.